ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000250132.2	Motesanib	Liver hepatocellular carcinoma	0.025004532	Resistant
ENSG00000250132.2	Motesanib	Brain lower grade glioma	0.037232603	Sensitive